Piper Sandler Downgrades Aeglea Biotherapeutics (AGLE) to Neutral
Tweet Send to a Friend
Piper Sandler analyst Edward A. Tenthoff downgraded Aeglea Biotherapeutics (NASDAQ: AGLE) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE